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e194 C. GROBET ET AL.Switzerland, which includes direct medical costs as well
as worker compensation claims; the latter is paid in
64% of cases, with a mean duration of 97 sick leave
days.1 Both nonoperative and operative treatments of
RC tears can lead to significant improvements over
time.2,3 Nontraumatic degenerative RC tears may be
primarily managed in a nonoperative manner.2-5 The
outcome of nonoperative treatment within the first 3
months has a prognostic value extending up to 5 years.6
However, up to 25% of these patients undergo surgery
within 1 and 5 years because of unsatisfactory
outcome.4 Traumatic and massive tears may benefit
from early surgery, with arthroscopic rotator cuff repair
(aRCR) providing substantial pain relief and increasing
shoulder function in affected patients.7
Triggered by rising health care costs, health economic
evaluations have become part of the assessment of
surgical interventions in orthopaedics.8 Yet cost-utility
analyses of upper-extremity interventions are rare
and mostly based on hypothetical scenarios and
modeled data derived purely from the literature.9 There
is a lack of using real-world datadcollected from indi-
vidual electronic health records of patients, claims and
billing activities, disease registries, etc.dto illustrate the
relationship between patient benefit reported in the
form of patient-reported outcome measures (PROMS)
and costs in a real-world setting. These data are
essential to assess the value of health care for society.10
In Switzerland, there is no explicit threshold prescribed
for society and its willingness to pay for a certain
amount of value: for example, costs involved for 1
additional quality-adjusted life year (QALY). Never-
theless, the threshold of 100,000 CHF/QALY has been
recommended for high-income countries.11
The purpose of this study was to assess the change in
quality of life (QOL) and costs for patients with RC tears
after aRCR compared with continued nonoperative
management using real-world evidence. The hypothesis
was that QOLwould substantially improve after surgery,
resulting in an acceptable cost-utility ratio for aRCR pa-
tients treated at a specialized Swiss orthopaedic hospital.
Methods
Design
A health economic investigation was performed to
assess patient benefits and costs associated with aRCR
compared with nonoperative management of RC tears
using a before-and-after-surgery comparison (pre-post
design). The study protocol was approved by the
Cantonal Ethics Committee of Zurich, Switzerland, and
was registered at ClinicalTrials.gov (NCT01954433).
Patients
Patients aged 18 years who were diagnosed with a
partial or complete RC tear indicated for aRCR andprovided written informed consent were eligible for
study inclusion. All consecutive patients with RC tears
of traumatic origin as well as patients with degenerative
tears were included. For the latter, an unsuccessful
nonoperative approach (i.e., after 3 months of phys-
iotherapy in combination with anti-inflammatory
medication) was seen as an indication for surgical
repair. Patients with irreparable tears were excluded.
Additional exclusion criteria included general medical
contraindications to surgery, any revision operation,
tumor/malignancy, any disease process that would
preclude accurate evaluation (e.g., neuromuscular,
psychiatric, or metabolic disorder), recent history of
substance abuse, legal incompetence, pregnancy, or
participation in any other study that could influence the
results of the present study. Eligible patients were
consecutively enrolled until a total of 150 patients were
operated and did not fulfill any exclusion criteria or
drop out within 2 weeks after surgery. Baseline pa-
rameters included patient sociodemographic data,
general health status, anamnesis, and shoulder condi-
tion. RC tears (partial or full-thickness tear and
involved tendons) were initially assessed using mag-
netic resonance imaging (MRI) and confirmed intra-
operatively according to a modified Patte
classification.12 Preoperative MRI was also used to
grade the extent of RC fatty infiltration.13
Operative Management and Rehabilitation
All aRCR patients were inpatients at a specialized
Swiss orthopaedic hospital. The surgical procedure was
performed according to standard internal and interna-
tional guidelines in a beach-chair position under gen-
eral anesthesia.14 Any repair procedure was carried out
or directly supervised by 1 of 7 experienced specialist
shoulder surgeons performing >50 aRCRs annually.
After diagnostic arthroscopy, the biceps tendon was
tenotomized when required, and for most patients,
standard acromioplasty was performed. The ruptured
tendons were mobilized until they could be reposi-
tioned on the original footprint with the least possible
tension. All surgeons used knotless suture bridge fixa-
tion, typically with 2 medial and 2 lateral anchors for
the supraspinatus. Additional medial anchors for the
subscapularis and infraspinatus were used as needed.
Rotator cuff tear patterns and associated pathologies,
operative details including repair techniques for each
involved tendon, and additional procedures (i.e., acro-
mioclavicular resection, acromioplasty, capsulotomy,
biceps treatment, and superior labrum anterior to pos-
terior treatment) as well as intraoperative complications
were recorded immediately after surgery.
All patients began a standard 3-phase postoperative
physiotherapy scheme for their operated shoulder,
which included 6 weeks of immobilization with an
abduction pillow and passive mobilization, followed by
Figure 1. Study flow. Patient recruitment and follow-up flowchart.
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Table 1. Baseline Characteristics
Characteristic
All aRCR Patients Trauma-OP Degen-OP
n (%) Mean (SD) n (%) Mean (SD) n (%) Mean (SD)
Patients 153 92 61
Age at surgery (y) 56.9 (8.2) 55.4 (8.1) 59.2 (8.0)
Male sex 97 (63) 66 (72) 31 (51)
Comorbidities 54 (35) 23 (25) 31 (51)
Duration of shoulder problems
<1 mo 22 (15) 21 (21) 1 (2)
1 to 3 mo 39 (25) 32 (35) 7 (11)
3 to 6 mo 29 (19) 14 (15) 15 (25)
6 mo to 1 y 33 (22) 17 (18) 16 (26)
>1 y 30 (20) 8 (9) 22 (36)
Working 110 (72) 75 (82) 35 (57)
Workload reduced before aRCR 31 (28) 28 (37) 3 (9)
Nonoperativeerative treatment
Steroid infiltration 49 (32) 20 (22) 29 (48)
Oral medication 122 (80) 77 (84) 45 (74)
Physical therapy 70 (46) 38 (41) 32 (52)
No treatment 14 (9) 7 (8) 7 (11)
Rotator cuff tear pattern
SSC 7 (5) 7 (8)
SSP 85 (56) 41 (45) 44 (72)
SSP and ISP 24 (16) 19 (21) 5 (8)
SSP and SSC 26 (17) 17 (18) 9 (15)
SSP and SSC and ISP 11 (7) 8 (9) 3 (5)
Tear severity*
Partial tear 29 (18) 10 (11) 19 (28)
Single full tear 71 (44) 39 (42) 32 (48)
Two or 3 tendons (only 1 full) 29 (18) 20 (22) 9 (13)
Massive tear 31 (19) 24 (26) 7 (10)
Fatty infiltration of involved RC musclesy
Stage 0 95 (62) 58 (65) 37 (57)
Stage 1 50 (32) 23 (26) 27 (42)
Stage 2 9 (6) 8 (9) 1 (2)
Patient-reported shoulder pain at night
Never or occasionally 68 (44) 39 (42) 29 (48)
Every night 85 (56) 53 (58) 32 (52)
Constant score (0 ¼ worst, 100 ¼ best) 146 48 (17) 88 44 (17) 58 53 (14)
Oxford Shoulder Score (0 ¼ worst, 48 ¼ best) 153 27 (8) 92 26 (8) 61 28 (8)
Subjective shoulder value (%) 152 48 (21) 92 47 (20) 60 49 (21)
EQ-5D-5L utility index (Germany) 152 0.71 (0.23) 92 0.72 (0.21) 60 0.69 (0.26)
EQ-VAS (0 ¼ worst, 100 ¼ best) 153 70 (18) 92 72 (16) 61 68 (19)
aRCR, arthroscopic rotator cuff repair; degen-OP, aRCR patients with degenerative rotator cuff tears; EQ-VAS, EQ-5D General Health Visual
Analogue Scale; ISP, infraspinatus; RC, rotator cuff; SD, standard deviation; SSC, subscapularis; SSP, supraspinatus; trauma-OP, aRCR patients
with traumatic rotator cuff tears.
*Gerber et al.27
yFuchs et al.13; using magnetic resonance imaging: stage 0, normal muscle; stage 1, some fatty streaks; stage 2, <50% fatty muscle atrophy.
e196 C. GROBET ET AL.active mobilization and coordination training for 4
weeks, and finally specific progressive resistance
exercises.
Patient-Reported and Clinical Outcomes
The primary outcome for this study was the change in
QOL and costs of aRCR. Patients were followed up at 7
time points throughout the study period: at enrollment
and at the time of hospital admission shortly before
surgery (both occurring within the 1-year preop
period), and at 2 weeks, 3 months, 6 months, and 1 and2 years after surgery (e-Supplement 1). Work status
and PROMS were documented at all 7 time points,
whereby patients completed questionnaires covering
QOL, shoulder function, employment conditions, re-
turn to work, and activities of daily living. Question-
naires were completed in electronic form either on a
tablet computer at the clinic or at home after receiving
an email invitation; patients preferring to complete the
questionnaires at home on a paper form returned their
responses by mail. QOL was assessed using the Euro-
pean Quality of Life 5 Dimensions 5 Level (EQ-5D-5L)
Figure 2. Utility index (EQ-
5D-5L) over time. Quality of
life (utility index) for arthro-
scopic rotator cuff repair pa-
tients as measured by the
European Quality of Life 5 Di-
mensions 5 Level (EQ-5D-5L)
questionnaire at each follow-
up time point (range e0.66 to
1.0; minimal clinically impor-
tant difference [MCID] ¼
0.074 points).23 The horizontal
dashed line indicates the utility
index for the health state we
assumed patients would
maintain throughout the
entire follow-up period if they
had not undergone surgery.
Figure 3. Shoulder function and quality of life over time.
Outcome scores for arthroscopic rotator cuff repair patients
are shown at each follow-up time point. Clinical examinations
for the Constant Score (range 0 to 100; minimal clinically
important difference [MCID] ¼ 8.3 points)28 were performed
up to the 6-month follow-up and patient-reported outcomes
up to 2 years after surgery. The original scale of the Oxford
Shoulder Score ranging from 0 to 48 was adapted to 0 to 100
for presentation purposes (MCID adapted for range 0 to 100 ¼
11.0 points).28 Subjective shoulder value: Subjective evalua-
tion of shoulder function by the patient in relation to normal
shoulder function (range 0% to 100%). EQ-VAS ¼ EQ-5D
General Health Visual Analogue Scale (range 0 to 100
points; MCID ¼ 7.18 points).28
COST-UTILITY ANALYSIS OF ROTATOR CUFF REPAIR e197questionnaire.15 The EQ-5D-5L responses were con-
verted into utilities (ranging from e0.66 [lowest QOL]
to 1 [highest QOL])15 using the EQ-5D-5L value set for
Germany.16 The EQ-5D is valid and reliable and the
most frequently used instrument to evaluate health
states using utilities and to calculate quality-adjusted
life years (QALYs).17 Patient-reported shoulder func-
tion was assessed using the Oxford Shoulder Score
(OSS)18 and subjective shoulder value (SSV).19
Routine clinical examinations were performed by
physicians at enrollment as well as the 3- and 6-month
postoperative time points, and by a study assistant at
the time of hospital admission shortly before surgery.
Examinations included shoulder range of motion and
muscle strength in 90 abduction, overall shoulder
function as measured by the Constant Score (CS),20 and
occurrence of postoperative complications.21
Cost and Productivity Data
Direct medical costs (all medical expenses including
aRCR-related costs) and productivity data of aRCR pa-
tients were collected for 3 time periods: (1) the year
before surgery (preop period), (2) surgery and the
consecutive first postoperative year, and (3) the second
postoperative year (e-Supplement 1). In a similar
manner, the costs and productivity data for patients
during nonoperative management were considered in
the year before enrollment as well as the first and
second years after enrollment. Sixteen major Swiss
health and accident insurance companies provided
direct medical inpatient and outpatient cost data
extracted from their claims database. Costs included all-
diagnosis direct medical costs of all treatments, com-
plications, drugs, and consultations covered by the
mandatory health and accident insurance companies,
pertaining to the inpatient and outpatient sector for
each patient across all hospitals and other providers. Allinpatient costs represent 45% of the total inpatient costs
in the Swiss health system, and therefore, these costs
were adjusted by dividing the provided inpatient costs
by 0.45.
Productivity losses due to shoulder complaints
resulting from a RC tear only were assessed at
Figure 4. Cost-effectiveness plot using direct medical costs.
Incremental cost-effectiveness ratio (ICER) for patients with
traumatic and degenerative rotator cuff tears (black and grey
bold lines, respectively) and the 95% confidence interval
(dashed lines). Incremental costs, direct medical costs; QALY,
quality-adjusted life years
Table 2. Direct medical costs and productivity losses in Swiss Francs (CHF)
n
Preoperative
Year (CHF)
First Postoperative
Year (CHF)
Second Postoperative
Year (CHF) n*
Incremental
Costs (CHF)
Operated
(aRCR)
patients
Direct medical
costs
130 5,499 (6,167) 17,116 (10,058) 4,226 (7,998) 116 5,009 (7,139)
Inpatient cost
data
130 963 (3,480) 12,129 (8,580) 1,872 (6,152)
Outpatient
cost data
130 4,535 (4,106) 4,987 (3,286) 2,354 (3,290)
Productivity
loss
88 42,001 (44,067) 25,565 (23,188) 5,415 (14,523)
Trauma-OP
patients
Direct medical
costs
77 4,313 (5,569) 14,843 (4,581) 1,531 (3,406) 66 3,704 (4,388)
Inpatient cost
data
77 657 (2,627) 10,659 (2,977) 352 (1,597)
Outpatient
cost data
77 3,656 (3,840) 4,183 (2,639) 1,179 (2,355)
Productivity
loss
59 49,547 (45,554) 28,325 (24,595) 4,438 (11,471)
Degen-OP
patients
Direct medical
costs
53 7,221 (6,626) 20,418 (14,197) 8,140 (10,742) 50 6,732 (9,420)
Inpatient cost
data
53 1,408 (4,428) 14,264 (12,722) 4,080 (9,043)
Outpatient
cost data
53 5,813 (4,180) 6,154 (3,778) 4,060 (3,707)
Productivity
loss
29 26,649 (37,030) 20,425 (19,686) 7,296 (19,211)
NOTE. Data are presented as mean (standard deviation).
aRCR, arthroscopic rotator cuff repair; degen-OP, aRCR patients with degenerative rotator cuff tear; trauma-OP, aRCR patients with traumatic
rotator cuff tear.
*Patients with complete cost data and corresponding quality-adjusted life years.
e198 C. GROBET ET AL.enrollment, at the time of hospital admission shortly
before surgery, and at 3 months, 6 months, and 1 and 2
years after surgery using the Work Productivity and
Activity Impairment Questionnaire e Specific Health
Problem Version 2.0 (WPAI-SHP)22 consisting of 6
questions on absenteeism (absence from work) and
presenteeism (reduced productivity when at work)
during the last 7 days. Additional work-related data
included (1) the number of hours usually worked per
week, (2) whether the level of employment had been
reduced due to the RC tear, (3) the duration of absence
from work after surgery, and (4) the current monthly
personal income in brackets of 2,000 CHF to 16,000
CHF.
Statistical Analysis
The power analysis considered a predetermined
sample size of 150 operated patients to detect a clini-
cally important change in QOL of 0.07423 in this group.
This calculation was based on a standard deviation of
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COST-UTILITY ANALYSIS OF ROTATOR CUFF REPAIR e1990.30, a significance level of 0.05, and a power of 80%
while considering a maximum loss to follow-up of
10%.
All data were entered into a web-based electronic
database using REDCap Software 6.16.5 (Vanderbilt
University, Nashville, TN)24 and exported for analysis
into Intercooled Stata 14.2 (StataCorp, College Station,
TX).
Baseline patient sociodemographic data and RC tear
diagnostic, functional, and operative parameters were
tabulated using standard descriptive statistics for all
operated patients and separately for traumatic aRCR
(trauma-OP) (classified by the accident date docu-
mented in the local clinic patient information system)
and degenerative aRCR (degen-OP) patients. The
change of QOL was analyzed using a paired t test and
reported as the mean with its 95% confidence interval
(95% CI). QALYs were calculated by multiplying utili-
ties with the length of time over which health state was
experienced. The assumption was that the health state
between 2 assessment points was equal to the mean of
the utilities recorded at these points. For the base case,
it was assumed that if patients had not undergone
surgery, they would have maintained their preopera-
tive health state throughout the follow-up period under
evaluation.
Annual direct medical costs (all-diagnosis costs
including aRCR-related costs) were calculated for each
1-year period. The incremental cost-effectiveness ratio
(ICER) was calculated by dividing the difference in
annual costs (postoperative period minus preop period)
by the difference in QALYs. Results were calculated for
the entire sample as well as for trauma-OP and degen-
OP patient subgroups. The 95% CIs of costs and ICER
were calculated using nonparametric bootstrapping
methods.25
Productivity losses for the patient population, which
had a labor type pattern representative of RC tear pa-
tients in Switzerland, were calculated by multiplying
the accumulated productivity losses due to health-
related (i.e., shoulder-specific) absenteeism and pre-
senteeism26 with annual earnings. These losses were
extrapolated over the time between 2 questionnaires.
For example, patients reporting to be still out of work 3
months after surgery who then reported working at
50% of their full-time level of employment 6 months
after surgery were considered as working at 25% of
their full-time level of employment between 3 and 6
months after surgery. Costs were reported in 2017 CHF
(conversion rate to USD, 1.03; to Euro, 0.85; to British
pound, 0.76). Current standards for performing health
economic evaluations were applied.8
The changes of all outcome parameters from baseline
to each follow-up assessment were analyzed using
generalized linear mixed models to account for repeated
measurements. The relationship between shoulder
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e200 C. GROBET ET AL.function (CS, SSV, OSS) and QOL utility index over time
was explored with scatter plots as well as regression
analysis, while adjusting for the baseline index.
Sensitivity Analysis
One major assumption in the primary analysis (base
case) of this study was that the QOL index of patients
continuing a hypothetical nonoperative management
would remain constant over time. However, 2 recent
meta-analyses highlighted that patients with degener-
ative tears who undergo intensified physiotherapy
instead of surgery would improve their QOL.2,3 Even
though these patients would not achieve the same QOL
levels as operated patients after 2 years of follow-up,
the difference would not exceed the minimal clinically
important difference (MCID). Therefore, a sensitivity
analysis was conducted to simulate an improvement in
QOL within the nonoperative treatment setting for the
whole patient group (hypothetical nonoperative group)
and for patients with degenerative tears (hypothetical
degen-nonoperative group).
In addition to the base case (i.e. no improvement in
QOL after nonoperative management), a linear increase
in QOL was simulated from the time point of a hypo-
thetical more intensive nonoperative treatment until
the 2-year follow-up using 4 values of mean utility of
the aRCR group (i.e., all operated patients): e5%;
e7.7% (corresponding to the MCID of e0.07 utilities);
e10%; and e15% (e-Supplement 2). In addition to the
base case (i.e., no increased costs), hypothetically
increased direct medical costs in the nonoperative and
degen-nonoperative group due to more intensive
nonoperative management in the year after enrollment
were also considered, assuming 110%, 120%, or 140%
of the documented costs of the preop year for the first
year after enrollment. The costs in the second year after
enrollment, in turn, were considered similar to the year
before enrollment.Results
Patient Enrollment and Baseline Characteristics
Between November 2013 and March 2015, 177 pa-
tients were enrolled (Figure 1). Twenty-four patients
(14%) were excluded because of ineligibility (including
7 who declined aRCR surgery), and 6 patients (4%)
dropped out during the study. The final sample
included 92 traumatic (60%) and 61 degenerative tears,
and the majority (94%) were hospitalized for 3 to 4
days. Table 1 summarizes the baseline characteristics,
PROMS, and clinical outcomes for all aRCR patients as
well as the subgroups, trauma-OP and degen-OP.
Patient-Reported and Clinical Outcomes
From a baseline value of 0.71, the EQ-5D utility index
dropped after surgery, but improved substantially by a
Figure 5. Return-to-work
rates over time. Kaplan-Meier
curve showing the percentage
of patients returning to work
after arthroscopic rotator cuff
repair; m, months; y, years.
COST-UTILITY ANALYSIS OF ROTATOR CUFF REPAIR e201mean of 0.26 for aRCR patients at the end of the first
and second postoperative years (P < .001; Figure 2);
similar observations were made for the trauma-OP and
degen-OP subgroups (e-Supplement 3). All other
baseline PROMS also improved substantially for the
aRCR as well as trauma-OP and degen-OP groups until
1 year after surgery and remained at that level in the
second postoperative year (P < .001; Figure 3 and e-
Supplement 3).
Cost-Utility Analysis
Direct cost data were obtained for 130 patients (85%)
who were insured by major Swiss insurance companies.
Mean direct costs increased from 5,499 CHF (5,664
USD) in the year before surgery (comprising mainly
outpatient costs) to 17,116 CHF (17,629 USD) in the
first year after surgery (comprising the costs of surgery),
with a shift toward increasing inpatient costs (Table 2);Figure 6. Productivity losses over time. Productivity losses of all
after surgery. The horizontal line between e4 and 0 weeks indicthis was followed by a decrease to 4,226 CHF (4,353
USD) in the second postoperative year, which was
below the mean cost incurred before surgery. The same
trend was seen for the trauma-OP and degen-OP sub-
groups, although second postoperative year costs were
higher than preoperative costs for the latter.
The ICER for all aRCR patients was 24,924 CHF/
QALY (95% CI, 16,742 to 33,106; 25,672 USD/QALY).
The corresponding ICER for the trauma-OP group was
17,357 CHF/QALY (95% CI 10,951 to 23,763; 17,878
USD/QALY) and 36,475 CHF/QALY (95% CI 16,301 to
56,648; 37,569 USD/QALY) for the degen-OP group
(Figure 4).
The sensitivity analyses resulted in ICERs ranging
from 50,712 to 19,237 CHF/QALY (52,233 to 19,814
USD/QALY) for the whole patient group (Table 3A) and
76,640 to 28,467 CHF/QALY (78,939 to 29,321 USD/
QALY) for patients with degenerative tears (Table 3B).arthroscopic rotator cuff repair patients (N ¼ 97) until 2 years
ates the preoperative period.
Figure 7. Association between quality of life and shoulder
function over time. Each data point represents 1 patient
preoperatively or 2 years after surgery. Scatter plot showing
the association between quality of life (indicated by the Eu-
ropean Quality of Life 5 Dimensions 5 Level [EQ-5D-5L]
utility index; range 0.0 to 1.0; minimal clinically important
difference [MCID] ¼ 0.074)23 and the Oxford Shoulder Score
(OSS; range 0 to 48; MCID ¼ 4.7 and 6.0 for shoulder pain
and function, respectively)29 before and 2 years after surgery.
The regression line indicates the association between quality
of life and OSS at the preoperative time point.
e202 C. GROBET ET AL.Among a total of 110 working patients in the aRCR
group, 31 patients (28%; 37% of 75 trauma-OP pa-
tients and 9% of 35 degen-OP patients) reduced their
work activity either preop or before study enrollment.
Preop productivity losses for 97 working patients with
complete data were 56% and 40% of the work activity
level for trauma-OP and degen-OP patients, respec-
tively; these losses peaked after surgery. Operated pa-
tients returned to work on average after 77 days
(Figure 5). Sixteen weeks after surgery, productivity
losses decreased below preop levels (Figure 6). Mean
productivity losses for the aRCR group were 42,001
CHF (43,261 USD) per patient in the year before sur-
gery and decreased to 5,415 CHF (5,577 USD) 2 years
after surgery (Table 2).
The OSS, SSV, and CS were significantly associated
with the EQ-5D index at both preop and 2-year-
postop time points (P < .001; Figure 7; EQ-5D index
vs SSV and CS scatter plots not shown). The co-
efficients of determination (R2) were 0.52, 0.46, and
0.42 for the OSS, SSV 2 years postop, and CS 6
months postop.Discussion
For patients who underwent aRCR for traumatic and
degenerative tears, there was a clinically relevant
improvement in quality of life from 3 months to 2 years
after surgery compared with the preop state, which was
associated with improved shoulder function. The cost-
utility ratio of aRCR was estimated at 24,924 CHF/
QALY, which clearly falls below the suggested threshold
of 100,000 CHF/QALY for high-income countries.11
This study presents real-world data for a consecutive
series of aRCR patients treated at a large orthopaedic
tertiary hospital. In contrast, the most recently pub-
lished health economic studies are based on modeling
techniques using estimated cost data.30-34 For the vast
majority of patients, standard nonoperative manage-
ment failed, and based on the judgment of the experi-
enced shoulder specialists, a different response to the
reported shoulder problems was to be expected with
surgery. Therefore, randomization of these patients
between aRCR and intensive physical therapy was
considered unethical and infeasible. The pre-post study
design of the current study is a suitable approach given
the circumstances of the clinical setting.
QOL as documented by the EQ-5D-5L utility index
improved significantly, by 0.26 points. This is well above
the estimated MCID of 0.074,23 which was calculated
from 11 patient groups not specifically including aRCR
patients. The existing data on change in QOL in upper-
extremity orthopaedic disorders using the EQ-5D-5L
instrument are very limited.17 The few studies report-
ing EQ-5D-5L utility indices for aRCR patients show
consistent improvement inQOLof 0.20 and 0.19 at 1 and
2 years after surgery.33,35 Furthermore, there is a QALY
gain of 1.34 at 2 years after aRCR,36 as well as a lifetime
QALY gain of either 3.4335 or 11.73.31
The ICER of aRCR patients was 24,924 CHF/QALY 2
years after surgery from a health care system perspec-
tive (base case). In the sensitivity analysis, the resultant
ICER of 47,820 CHF/QALY for aRCR still falls below the
cost-effectiveness threshold, even when considering a
conservative assumption (QOL values: for the hypo-
thetical nonoperative group, 5% less compared with
aRCR patients; costs: slightly increased costs of 110%
for more intensive nonoperative treatment compared
with the year before enrollment). Two independent
studies that compared aRCR versus nonoperative
management found similar ICERs of 15,500 USD
(15,106 CHF) and 30,001 GBP (39,501 CHF) per QALY,
respectively.31,36 Yet most of the work already pub-
lished applied modeling techniques using estimated
utility and cost data extracted from the literature.30-32,34
Studies reporting on primary health economic data are
rare. A prospective cost-utility study analyzed patients
who underwent open or mini-open RC tear repair,35
and 3 prospective health economic investigations
COST-UTILITY ANALYSIS OF ROTATOR CUFF REPAIR e203compared aRCR with physiotherapy or open RC
repair5,33,36 in patients aged >50 years with degenera-
tive full-thickness tears. Two studies were conducted
from a health care system perspective using direct
medical costs for ICER calculation.33,35 The remaining
studies considered the societal perspective by analyzing
productivity losses due to sick leave,5,36 but either
compared aRCR with open repair36 or did not report an
ICER.5 A comparison of results across studies requires
consideration of the case mix. Traumatic RC tear pa-
tients included in the current study were younger, less
affected by comorbidities, and more often employed
than patients affected by degenerative tears. These pa-
tient groups generate varying amounts of direct medical
costs and productivity losses, which are likely related to
their different demographic and health profiles.
Shoulder problems generated substantial preopera-
tive productivity losses, with 80% of working patients
having impairments, particularly those in the trauma-
OP group, possibly owing to the presence of more se-
vere RC lesions. Although return to work and
increasing workloads were attained after an average of
77 postoperative days, it is unlikely that aRCR patients
would have achieved a better working status if they had
not undergone surgery. Nevertheless, it is not possible
to speculate on what their status would have been, and
therefore the associated costs were not included in the
ICER calculation. Furthermore, the ICER considers only
2 years of follow-up, although the treatment effect of
aRCR is expected to last far longer. Previous cost-utility
studies considered the patient’s remaining lifetime and
noted good to excellent results for >90% of RCR pa-
tients, as well as low long-term revision rates at post-
operative follow-ups ranging from 2 to 10 years.30,35
Those studies assumed that expenses in the first post-
operative year capture the majority of costs associated
with RCR, and that fewer downstream costs would
follow. Further investigation is required to assess
whether a more favorable ICER would be achieved for
aRCR with the studied patient collective over a long-
term follow-up extending beyond 2 years.
Limitations
One main study limitation is the lack of a randomized
study design.8 However, a pre-post design, which has
already been applied elsewhere,37 was considered most
feasible in this clinical setting; patients with traumatic
tears or persisting pain after nonoperative management
mainly consult specialty tertiary referral hospitals such
as our clinic. With only 7 patients who declined surgery
and had baseline characteristics poorly comparable to
the aRCR patients, it proved inadequate to build an
appropriate control group. Such an obstacle was
encountered in another large cost-utility study owing to
a high rate of crossovers to surgery (77%) within 2years after enrollment,36 as well as another more recent
study with a 10-year follow-up period (27%) from the
group of Moosmayer.38 The high proportion of patients
with previously unsuccessful nonoperative treatment
contributed to the difficulties that were encountered in
achieving a sizable comparison group who would have
undergone continued and more intensive nonoperative
care. By using preop data for comparative purposes, the
strong assumption was that aRCR patients would
remain in their same condition without surgery. With
the sensitivity analyses, alternative scenarios were
applied based on previous reports,2,3 which considered
successful nonoperative management for the whole
patient group as well as for patients with degenerative
tears. However, it is still unclear how likely these sce-
narios truly apply to the study patients. Furthermore, it
must be considered that only all-diagnoses direct
medical costs were available, which included costs of
other health-related comorbidities or complications due
to aRCR. Because of the pre-post study design, the use
of this comprehensive cost data should nonetheless
have limited impact on incremental costs, and any cost
due to potential side effects of surgery can also be
examined. Lastly, the results of this study need to be
considered in terms of the local surgical routine un-
dertaken at our clinic, and may differ in other in-
stitutions located particularly outside Switzerland.
Conclusions
For RC patients treated at a specialized Swiss ortho-
paedic clinic, aRCR is a cost-effective intervention
associated with clinically relevant improvement in QOL
up to 2 years after repair compared with prior nonop-
erative management.Acknowledgments
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